#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy Amyloidosis Pulmonary alveolar haemorrhage Partial lipodystrophy Acute myeloid leukaemia Chemical burn Li-Fraumeni syndrome Burkitt's lymphoma refractory Immunoglobulin G4 related disease Hypereosinophilic syndrome Peritoneal mesothelioma malignant Autoimmune haemolytic anaemia Waldenstrom's macroglobulinaemia Philadelphia positive chronic myeloid leukaemia Idiopathic inflammatory myopathy More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Basic Information Medulloblastoma recurrent – Diagnostics Uterine leiomyosarcoma – Life with Disease Lymphangiosarcoma – Diagnostics Carcinoid syndrome – Basic Information Isodicentric chromosome 15 syndrome – Life with Disease Burkitt’s lymphoma – Life with Disease Activated PI3 kinase delta syndrome Rosai-Dorfman syndrome – Diagnostics Acquired haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Celecoxib ZILEBESIRAN Siltuximab Tenofovir Disoproxil Fumarate Meldonium SOFTISAN 378 Ucart22 Perampanel Quavonlimab Pyruvic Acid Glutathione Troriluzole Gadoteric Acid Pyrimethamine Ltx-315 POTASSIUM HYDROXIDE ROC-101 HYDROCHLORIDE SIPAVIBART Lovo-A Ebastine More therapies…

    Learn about Your Condition

    Pulmonary resection Breast cancer metastatic End stage renal disease Breast cancer stage III Tendon rupture Angiosarcoma metastatic Ocular myasthenia Epiphysiolysis Lymphangiosarcoma Lung adenocarcinoma stage III Primary biliary cholangitis Fatty acid oxidation disorder Complex regional pain syndrome Gastrointestinal carcinoma Bronchiectasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mkmrnd Zklojqsc Kkghb 2sc Dsnrdydye 4ghyo Huxwymx

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Durvalumab
    • Infliximab
    Austria Belgium Bulgaria Denmark Finland France +6

  • Study Comparing Acalabrutinib to Standard Treatments for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Acalabrutinib
    Croatia Czechia Hungary Poland

  • Study Comparing Sacituzumab Govitecan to Physician’s Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Carboplatin
    • Gemcitabine
    • Paclitaxel
    Austria Belgium Czechia France Germany Hungary +6

  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cold urticaria
    Investigated Drugs:
    • Barzolvolimab
    Bulgaria Germany Hungary Latvia Lithuania Poland +1

  • Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Azd5004
    • Semaglutide
    Germany Hungary Poland Slovakia Spain

  • Study of dapagliflozin effects in patients hospitalized with acute heart failure

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Dapagliflozin Propanediol Monohydrate
    Czechia Hungary Poland

  • Study Comparing Paclitaxel, Carboplatin, and Oregovomab with Paclitaxel, Carboplatin, and Placebo for Patients with Advanced Ovarian Cancer

    Not recruiting

    3 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Oregovomab
    Belgium Czechia Hungary Italy Spain

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Volrustomig
    • Carboplatin
    • Infliximab
    Austria Belgium Czechia France Germany Hungary +5
Previous Page
1 … 31 32 33 34 35 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!